ArticleProceedings of the National Academy of Sciences of the United States of America2019

Increased Muscleblind levels by chloroquine treatment improve myotonic dystrophy type 1 phenotypes in in vitro and in vivo models.

Ariadna Bargiela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.